» Articles » PMID: 36713835

Modifiable Factors for Migraine Prophylaxis: A Mendelian Randomization Analysis

Overview
Journal Front Pharmacol
Date 2023 Jan 30
PMID 36713835
Authors
Affiliations
Soon will be listed here.
Abstract

To examine the causal effect of potentially modifiable risk factors contributing to migraine pathogenesis. We performed Mendelian randomization analyses and acquired data from United Kingdom Biobank, FinnGen Biobank, and the MRC IEU OpenGWAS data infrastructure. An inverse-variance weighted (IVW) model was used to examine the relationship between 51 potentially modifiable risk factors and migraine in 3215 participants with migraine without aura (MwoA), 3541 participants with migraine with aura (MwA), and 176,107 controls. We adopted a Bonferroni-corrected threshold of = 9.8 × 10-4 (.05 divided by 51 exposures) as a sign of significant effect, and a < .05 was considered as the sign of a suggestive association. More years of schooling significantly correlated with lower odds of MwoA pathogenesis (OR .57 [95%CI .44 to .75], < .0001). More vitamin B12 intake (OR .49 [95%CI .24 to .99], = .046) and lower level of stress [OR 8.17 (95%CI 1.5 to 44.36), = .015] or anxiety disorder (OR 1.92 × 109 [95%CI 8.76 to 4.23*1017], = .029) were suggestive to be correlated lower odds of MwoA pathogenesis. More coffee intake (OR .39 [95%CI .22 to .7], = .001), lower level of eicosapentaenoic acid status (OR 2.54 [95%CI 1.03 to 6.26], = .043), and more light physical activity (OR .09 [95%CI .01 to .94], = .046) were suggestive to be associated with lower odds of MwA. The years of schooling, light physical activity, vitamin B12 intake, and coffee intake were the protective factors for migraine; stress, anxiety, and eicosapentaenoic acid status were harmful factors. Interventions could be developed based on modifying these factors for migraine prophylaxis.

Citing Articles

Early detection of Parkinson's disease through multiplex blood and urine biomarkers prior to clinical diagnosis.

Gao S, Wang Z, Huang Y, Yang G, Wang Y, Yi Y NPJ Parkinsons Dis. 2025; 11(1):35.

PMID: 39994191 PMC: 11850829. DOI: 10.1038/s41531-025-00888-2.


[Causal Relationship Between Components of Metabolic Syndrome and Endometrial Carcinoma].

Yang M, Hu Y, Guo W, Yang F, Qi X, Zheng Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2025; 55(6):1557-1566.

PMID: 39990839 PMC: 11839343. DOI: 10.12182/20241160109.


Integrative analyses of mendelian randomization and bioinformatics reveal casual relationship and genetic links between COVID-19 and knee osteoarthritis.

Zheng X, Li J, Ma Q, Gong J, Pan J BMC Med Genomics. 2025; 18(1):2.

PMID: 39748395 PMC: 11697936. DOI: 10.1186/s12920-024-02074-4.


Causal effects of systemic inflammatory proteins on Guillain-Barre Syndrome: insights from genome-wide Mendelian randomization, single-cell RNA sequencing analysis, and network pharmacology.

Liu J, Pan R Front Immunol. 2024; 15:1456663.

PMID: 39315093 PMC: 11416972. DOI: 10.3389/fimmu.2024.1456663.


Genetic interactions and pleiotropy in metabolic diseases: Insights from a comprehensive GWAS analysis.

Shen J, Pan J, Yu G, Cai H, Xu H, Yan H J Cell Mol Med. 2024; 28(17):e70045.

PMID: 39238070 PMC: 11377178. DOI: 10.1111/jcmm.70045.


References
1.
Couch J . Amitriptyline in the prophylactic treatment of migraine and chronic daily headache. Headache. 2010; 51(1):33-51. DOI: 10.1111/j.1526-4610.2010.01800.x. View

2.
Brusa P, Parente M, Allais G, Rolando S, Costa G, Gnavi R . Community pharmacies as epidemiological sentinels of headache: first experience in Italy. Neurol Sci. 2017; 38(Suppl 1):15-20. DOI: 10.1007/s10072-017-2908-7. View

3.
Hemani G, Zheng J, Elsworth B, Wade K, Haberland V, Baird D . The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018; 7. PMC: 5976434. DOI: 10.7554/eLife.34408. View

4.
Barber M, Pace A . Exercise and Migraine Prevention: a Review of the Literature. Curr Pain Headache Rep. 2020; 24(8):39. DOI: 10.1007/s11916-020-00868-6. View

5.
Spadea T, Scarinzi C, Baratta F, Allais G, Rolando S, Manzoni G . Access to migraine centres by educational level of patients and awareness of the disease. Neurol Sci. 2019; 40(Suppl 1):207-209. DOI: 10.1007/s10072-019-03819-1. View